Olivier Séror
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 55
- Liver Disease and Transplantation 19
- Hepatitis C virus research 6
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 44
- Hepatitis B Virus Studies 8
- Biotechnology top 5%
- Microbial Inactivation Methods 10
- Cancer Research top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Ultrasound and Hyperthermia Applications 6
- Co-authors
- Nathalie Ganne‐CarriéPierre NahonG. NkontchouMichel BeaugrandJean‐Charles NaultN. SellierOlivier SutterJean–Claude Trinchet
- Cited by
- HepatologyEpidemiologyBiotechnology
- Partner nations
- FranceItalySwitzerland
In The Last Decade
Olivier Séror
93 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Hepatology 1.8k
- Epidemiology 1.2k
- Biotechnology 166
- Cancer Research 266
- Radiology, Nuclear Medicine and Imaging 369
Countries citing papers authored by Olivier Séror
This map shows the geographic impact of Olivier Séror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Séror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Séror more than expected).
Fields of papers citing papers by Olivier Séror
This network shows the impact of papers produced by Olivier Séror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Séror. The network helps show where Olivier Séror may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier Séror, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 21 | |
| 4 | 2024 | 13 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 29 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 2 | |
| 12 | 2019 | 23 | |
| 13 | 2018 | 11 | |
| 14 | 2018 | 14 | |
| 15 | 2018 | 40 | |
| 16 | 2013 | 65 | |
| 17 | 2012 | 64 | |
| 18 | 2011 | 0 | |
| 19 | 2009 | 355 | |
| 20 | 2008 | 20 |
About Olivier Séror
Olivier Séror is a scholar working on Hepatology, Epidemiology and Biotechnology, having authored 102 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Liver Disease Diagnosis and Treatment (44 papers), Liver Disease and Transplantation (19 papers), Microbial Inactivation Methods (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatitis B Virus Studies (8 papers), Ultrasound and Hyperthermia Applications (6 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.2k citations) and Biotechnology (166 citations). Olivier Séror has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include Nathalie Ganne‐Carrié, Pierre Nahon, G. Nkontchou, Michel Beaugrand, Jean‐Charles Nault, N. Sellier, Olivier Sutter, Jean–Claude Trinchet, Emmanuelle Coderc and Jean Claude Trinchet. Their work appears in journals such as Hepatology, Gut and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.